학술논문

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial
Document Type
Article
Source
In: Oncologist. (Oncologist, August 2021, 26(8):e1327-e1338)
Subject
Language
English
ISSN
1549490X
10837159